Analyst Ratings for Halozyme Therapeutics (HALO)
HALO Rating Summary
HALO Price Target Summary
- Highest: $73.00 (JMP Securities)
- Lowest: $49.00 (Goldman Sachs)
- Average: $61.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$61.30 (+27.2%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 69%
Avg. $ Target:
$61.30 (+27.2%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/7/2024 | Wells Fargo | Mohit Bansal | Downgrade | Equal Weight (Overweight) |
62.00 (58.00) |
59.18 (48.20) |
-18.55% | Details |
| 9/19/2024 | JPMorgan | Jessica Fye | Downgrade | Neutral (Overweight) |
57.00 (52.00) |
61.93 (48.20) |
-22.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
